Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-completion-of-enrollment-in-phase-2-venture-oral-dosing-trial-of-vk2735-tablet-formulation-in-patients-with-obesity-302411564.html
12 Mar 2025
// BIOSPACE
https://www.biospace.com/business/viking-secures-1b-supply-of-obesity-pill-candidate-with-150m-prepayment-deal
14 Feb 2025
// REUTERS
https://www.reuters.com/business/aerospace-defense/hedge-fund-viking-buys-boeing-shares-filing-shows-2025-02-14/
29 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viking-therapeutics-to-report-financial-results-for-fourth-quarter-and-year-end-2024-on-february-5-2025-302362497.html
08 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-initiation-of-phase-2-venture-oral-dosing-trial-of-vk2735-tablet-formulation-in-patients-with-obesity-302345159.html
19 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viking-therapeutics-presents-results-from-phase-2b-voyage-study-of-vk2809-in-biopsy-confirmed-nashmash-at-the-75th-liver-meeting-2024-302310271.html
Excipients
ABOUT THIS PAGE